Skip to main content
. 2016 Feb 17;16(4):1193–1206. doi: 10.1111/ajt.13598

Table 3.

BKPyV EVGR‐specific T cell responses in kidney transplant recipients

IFN‐γ ELISpot MHC‐streptamers
HLA type BKPyV epitope Tested KTRs (n) KTRs with positive response (%) SFU/106 cells (mean) Tested KTRs (n) KTRs with positive response (%) Epitope‐specific CD8+ T cells (mean %)
A*01 256 2 50 100
327 2 100 40 3 67 0.10
386 3 33 0.02
A*02 316 5 20 0.14
302 8 12 245
389 9 67 312
391 4 25 840
393 3 33 0.06
510 10 50 95
536 4 25 0.14
679 9 89 324 11 36 0.09
A*03 256 3 30 120
272 3 67 0.12
327 3 30 270 1 100 0.05
A*11 256 3 30 120
276 3 30 465
327 3 67 270 3 33 0.08
389 3 33 70
A*24 127 3 33 200
342 1 100 0.08
389 4 50 370 2 50 0.02
B*07 119 2 50 130 2 50 0.07
127 2 100 280 2 50 0.08
240 1 100 0.03
301 1 100 0.09
389 2 50 285
B*08 127 1 100 150
462 1 100 0.08
679 1 100 0.07
B*35 240 5 80 410
391 5 40 590
633 5 40 145
B*51 256 4 25 180
389 5 40 135 2 50 0.10
506 2 100 175

BKPyV, BK polyomavirus; EVGR, early viral gene region; IFN‐γ, interferon γ; KTR, kidney transplant recipient; SFU, spot‐forming unit.